home / stock / cmps / cmps articles


CMPS Articles, COMPASS Pathways Plc - From 10/22/23

Stock Information

Company Name: COMPASS Pathways Plc
Stock Symbol: CMPS
Market: NASDAQ
Website: compasspathways.com

Menu

CMPS CMPS Quote CMPS Short CMPS News CMPS Articles CMPS Message Board
Get CMPS Alerts

News, Short Squeeze, Breakout and More Instantly...

Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted | Benzinga

Jada Pinkett Smith Opens Up About Ayahuasca: It Helped Her Overcome Depression And Suicidal Thoughts Jada Pinkett Smith has joined the growing numb...

Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More | Benzinga

Cybin And Small Pharma Shareholders Green Light Acquisition Resolution Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) an...

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More | Benzinga

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary...

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More | Benzinga

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy...

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More | Benzinga

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Billionaire hedge fund and NY Mets own...

How COMPASS Pathways Is Leveraging AI To Revolutionize The Mental Healthcare Space | Benzinga

Artificial Intelligence (AI) is rapidly penetrating a number of different sectors, including healthcare. The use of AI in mental health has opened ...

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More | Benzinga

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next MAPS Public Benefit Corporation (MAPS PBC), the nonprofi...

COMPASS Pathways appoints Daphne Karydas to its Board of Directors | Benzinga

LONDON, Sept. 18, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (NASDAQ:CMPS) ("COMPASS"), a biotechnology company dedicated to accelerating pat...

Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative | Benzinga

The Norrsken Foundation, a non-profit impact ecosystem “connecting founders with the capital, knowledge and network they need to make saving ...

NY Consulting Firm Predicts Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years | Benzinga

NY-based strategic consulting firm Research Nester launched global market research for psychedelic substances with projections until 2035...

Previous 10 Next 10